Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Medical Tourism Experts

Analysis of: Hospitals See Drop in Paying Patients (www.nytimes.com)
Not just hospitals, but many players will see receivables drop including wellness and disease management companies, imaging diagnostics and labs, and soon manufacturers.
Analysis of: Healthcare Tech Companies Could Benefit from Obama Plan (money.cnn.com)
President-Elect Obama made reforming the U.S. healthcare system a central plank of his campaign.  A key initiative calls for spending $10 billion a year over the next five years ($50 billion total) to computerize health records and prescribe more treatments digitally. 
Analysis of: Congressional Democrats are Drafting a New Health IT Bill (www.govhealthit.com)
Although dealing with the financial crisis will still occupy much of the time and focus of the new Congress and President early in 2009, the need to control the costs of healthcare will not be far behind.  Both candidates for President are pushing for much more health IT as critical to achieving...
Analysis of: Prescription for Change (online.wsj.com)
The health care industry is on the brink of joining the 21st Century (or at least the late 20th Century).    Healthcare is about to undergo a global revolution that it can no longer resist with information technology as the fuel.  This transformation will occur because the previous barrier...
Analysis of: Small Practices to get Financial Boost with new Health IT Incentive Program (www.healthimaging.com)
Even after the trillion dollars which the federal government has had to spend to prop up the nation's financial system during the past month, it still has some real money left to subsidize the costs of physicians in smaller practices willing to implement electronic records.  With electronic records...
Richard Baland, Partner
Richard Baland, Partner
B2B CFO
Analysis of: Stark Offers Bill to Hasten e-record Adoption (modernhealthcare.com)
This will soon be the best time in history to be selling Healthcare IT software and services. More money will be spent in the next three years than ever before. It may not be the best time for the staff at many hospitals. The staff are woefully unprepared for a quantum leap in Healthcare Technology
Analysis of: CMS-eRX: Officals Lay out Cost-Benefit Analysis of E-Prescribing Bonuses (www.medpagetoday.com)
Despite all the studies and reports touting hundreds of billions of dollars of savings from electronic medical records, the adoption rate especially by physicians in smaller practices remains woefully low.  The biggest barrier still remains costs.   Implementing electronic medical...
Analysis of: 'Never Events' a Factor in Liability Costs (www.modernhealthcare.com)
This week the federal government implemented its long awaited and often controversial policy not to reimburse hospitals for the extra costs of treating patients who experience during the admission one or more of 11 so-called "never events".  Dozens of states, insurers and others are following...
Analysis of: CMS Value-Based Purchasing Initiatives to Grow (modernhealthcare.com)
Despite the mixed results of value-based purchasing of healthcare services (sometimes known as "Pay for Performance"), this new financing model is poised for significant growth in the years ahead.  The main reason for this is that based on current cost growth, the Medicare Part A trust fund...
Analysis of: Raising the Profile of Cancer of Unknown Primary (jco.ascopubs.org)
Diagnostic uncertainty in metastatic cancer as to the site of origin remains a problem in medicine today, albeit a slowly shrinking one. Immunohistochemistry using monoclonal antibodies from a host of makers will remain the mainstay in defining the site of origin, but it's proper use depends on accurate...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 Next11 to 20 of 667

Analytics


Generated at 2009-01-07T19:00:58.307